Fibrocell Science, Inc. (FCSC)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.89-0.03 (-3.26%)
At close: 4:00 PM EDT
People also watch:
SYNCRMDOGENFATEZIOP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.91
Prev Close0.92
Bid0.85 x 1000
Ask1.08 x 3300
Day's Range0.89 - 0.96
52wk Range0.89 - 6.75
1y Target EstN/A
Market Cap39.07M
P/E Ratio (ttm)-1.20
Beta0.88
Volume127,787
Avg Vol (3m)455,892
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETF’s with exposure to Fibrocell Science, Inc. : August 23, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Fibrocell Science, Inc. Here are 5 ETF’s with the largest exposure to FCSC-US. Comparing the performance and risk of Fibrocell Science, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube14 days ago

    ETF’s with exposure to Fibrocell Science, Inc. : August 11, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Fibrocell Science, Inc. Here are 5 ETF’s with the largest exposure to FCSC-US. Comparing the performance and risk of Fibrocell Science, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • American City Business Journals16 days ago

    Gene therapy company scraps public stock offering for private financing

    The Exton, Pennsylvania cell and gene therapy company will issue up to $25 million in convertible promissory notes and warrants to purchase common stock to investors in a private placement. The company plans to issue 10-year notes that are convertible into Fibrocell common stock at a conversion price of $1.14 per share, and will accrue interest at a rate of 4 percent annually. Each $1 of principal invested in the notes entitles the investor to a five-year warrant to purchase one share of the company’s common stock at an exercise price equal to $1.50 per share.